OTC · Drug Manufacturers - Specialty & Generic

Bionoid Pharma, Inc. (BINP) Stock

$0.03 +0.00% OTC: BINP Healthcare

Bionoid Pharma, Inc. functions as a medical technology enterprise.

Valuation

MetricValue
Price$0.03
Market Cap$1.62M
P/E Ratio-3.53
P/B Ratio0.41
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.45
52-Week Low$0.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-11.65%
ROA-11.22%
ROCE-11.61%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio0.00

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$-11.88$0.00$0.00$0.00$0.00
Op Margin-106.0%-78.2%5.2%36.0%—

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$0$0$0$0—
Total Liabilities$0$0$0$0—
Cash$0$0$0$0—
Borrowings$0$0$0$0$0

Latest News

If I Were Starting Over With $500 to Invest, I'd Begin by Building a Portfolio Around This Unstoppable Stock Motley Fool · Jul 26, 2026 How Much XRP (Ripple) Is Enough to Retire? 24/7 Wall St. · Jul 26, 2026 Trump, Hegseth attend dignified transfer of 4 soldiers killed in Middle East CBS News Videos · Jul 26, 2026 Berlin mourns deadly Islamist Pride attack as police hunt for suspect AFP · Jul 26, 2026 Neocloud Stocks vs. the Hyperscalers -- Who Actually Wins AI Capex Boom? Motley Fool · Jul 26, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$0$0$0$0—
Investing Cash Flow$0$0$0$0—
Financing Cash Flow$0$0$0$0—
Net Cash Flow$0$0$0$0—
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA-14.83
FCF Yield0.00%
Quick Ratio0.00
Interest Coverage-559.47
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BMCSBioTech Medics, Inc. $0.00 — -13.86 $41071 0.00%
BMMJBody and Mind Inc. $0.00 — -0.11 $29537 0.00%
CBDYTarget Group Inc. $0.00 — -0.41 $740431 0.00%
CTTHCTT Pharmaceutical Holdings, Inc. $0.07 +8.02% -26.40 $1.41M 0.00%
EDXCEndexx Corporation $0.00 — -0.02 $57185 0.00%

About Bionoid Pharma, Inc.

Bionoid Pharma, Inc. functions as a medical technology enterprise. This company concentrates on the creation and commercialization of advanced medical instruments and solutions, primarily targeting the orthopedic and pain management industries. Founded on October 20, 1997, its corporate headquarters are situated in Beverly Hills, California.

Bionoid Pharma, Inc. is headquartered in US.

Bionoid Pharma, Inc. (BINP) stock trades at $0.03 with a market capitalization of $1.62M. The stock is valued at a price-to-earnings (P/E) ratio of -3.53, price-to-book of 0.41, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.02 and $0.45, and currently trades 93.3% below its 52-week high.

On profitability, Bionoid Pharma, Inc. generates a return on equity (ROE) of -11.65%, return on capital employed of -11.61%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: bionoidinc.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides